Dr. Gregory has held senior positions with numerous pharmaceutical companies over the last two decades. As Senior Vice President of Business Development for a top bio-capital enterprise, his efforts led to the development of several new US pharmaceutical companies.
Mr. Stimits has 15-years’ experience in the pharmaceutical industry having served as the Vice President of Business Development and Licensing at a leading life sciences firm engaged in proprietary drug development, asset management and private equity.
Gerald Wolf, Ph.D., M.D.
Dr. Wolf received his M.D., cum laude, from Harvard Medical School, and also has a Ph.D. in Pharmacology and Physiology. He is a renowned expert in FDA, ICH and other regulatory requirements and guidelines governing clinical research.
Frank A. Snyder, M.S., M.D.
Dr. Snyder is one of the originators of the CardiaPill concept. He holds an advanced degree in molecular biology and is a Medical Doctor. He is an Associate Professor of Medicine at the University of North Carolina at Chapel Hill and an Adjunct Professor in the Vascular Biology Working Group.